Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 51-60 of 93 for

Edit search filters
  1. A Study to Evaluate the Effectiveness and Safety of RalinEpag for Improving Treatment Outcomes in PAH Patients

    Jacksonville, FL

  2. A Study of an Implantable System for Remodulin Post Approval

    Rochester, MN

  3. A Study to Evaluate the Effectiveness and Safety of Remdesivir to Treat Coronavirus Disease 2019 in an Outpatient Setting

    Rochester, MN

  4. Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension

    Rochester, MN

  5. A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH)

    Jacksonville, FL

  6. Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure

    Rochester, MN

  7. GS-4997 in Adults With Pulmonary Arterial Hypertension

    Rochester, MN

  8. A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Are Gene Variants that are Associated with Acute Vasoreactivity in Idiopathic Pulmonary Arterial Hypertension (IPAH) also Present in a Patient with Associated PAH due to Scleroderma

    Jacksonville, FL

  10. A Study of Alveolar-Capillary Recruitment as a Screening and Tracking Tool for Patients with Pulmonary Arterial Hypertension

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer